Literature DB >> 12125346

In vitro model of oxidative stress in cortical neurons.

Rajiv R Ratan1, Hoon Ryu, Junghee Lee, Aziza Mwidau, Rachel L Neve.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12125346     DOI： 10.1016/s0076-6879(02)52018-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  15 in total

1.  Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity.

Authors:  Klaus van Leyen; Ambreena Siddiq; Rajiv R Ratan; Eng H Lo
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

2.  Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1.

Authors:  Maria K Lehtinen; Saara Tegelberg; Hyman Schipper; Haixiang Su; Hillel Zukor; Otto Manninen; Outi Kopra; Tarja Joensuu; Paula Hakala; Azad Bonni; Anna-Elina Lehesjoki
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

3.  STAT-dependent upregulation of 12/15-lipoxygenase contributes to neuronal injury after stroke.

Authors:  Joo Eun Jung; Hulya Karatas; Yu Liu; Ayfer Yalcin; Joan Montaner; Eng H Lo; Klaus van Leyen
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-15       Impact factor: 6.200

4.  Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice.

Authors:  Junghee Lee; Bela Kosaras; Steve J Del Signore; Kerry Cormier; Ann McKee; Rajiv R Ratan; Neil W Kowall; Hoon Ryu
Journal:  Acta Neuropathol       Date:  2010-12-16       Impact factor: 17.088

5.  12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress.

Authors:  Stefanie Pallast; Ken Arai; Xiaoying Wang; Eng H Lo; Klaus van Leyen
Journal:  J Neurochem       Date:  2009-09-08       Impact factor: 5.372

6.  A large-scale chemical screen for regulators of the arginase 1 promoter identifies the soy isoflavone daidzeinas a clinically approved small molecule that can promote neuronal protection or regeneration via a cAMP-independent pathway.

Authors:  Thong C Ma; Aline Campana; Philipp S Lange; Hsin-Hwa Lee; Kasturi Banerjee; J Barney Bryson; Lata Mahishi; Shabnam Alam; Roman J Giger; Stephen Barnes; Sidney M Morris; Dianna E Willis; Jeffrey L Twiss; Marie T Filbin; Rajiv R Ratan
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

7.  Novel lipoxygenase inhibitors as neuroprotective reagents.

Authors:  Klaus van Leyen; Ken Arai; Guang Jin; Victor Kenyon; Bettina Gerstner; Paul A Rosenberg; Theodore R Holman; Eng H Lo
Journal:  J Neurosci Res       Date:  2008-03       Impact factor: 4.164

Review 8.  Lipoxygenase: an emerging target for stroke therapy.

Authors:  Klaus van Leyen
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-03       Impact factor: 4.388

9.  Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways.

Authors:  Ambreena Siddiq; Leila R Aminova; Carol M Troy; Kyungsun Suh; Zachary Messer; Gregg L Semenza; Rajiv R Ratan
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

10.  A screen for inducers of p21(waf1/cip1) identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor properties.

Authors:  Thong C Ma; Brett Langley; Brian Ko; Na Wei; Irina G Gazaryan; Neela Zareen; Darrell J Yamashiro; Dianna E Willis; Rajiv R Ratan
Journal:  Neurobiol Dis       Date:  2012-08-27       Impact factor: 5.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.